Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

451 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

NCT04853576

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Smilow Cancer Hospital New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View all 24 locations
View Trial Details
Active, not recruiting

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

NCT04786028

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Nova Scotia Health - QEII Health Sciences Centre Halifax, Nova Scotia, Canada
  • Hamilton Health Sciences Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital General Campus Ottawa, Ontario, Canada
View Trial Details
Completed

Horse-assisted Interventions in an Oncological Centre

NCT07831460

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS Meldola, FC, Italy
  • Santa Maria delle Croci Hospital Hematology Department, AUSL Romagna Ravenna, RA, Italy
  • Infermi Hospital Hematology Department, AUSL Romagna Rimini, Italy
  • Infermi Hospital Onco - Hematology Pediatric Department Rimini, Italy
View Trial Details
Completed

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

NCT03745287

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Lucile Packard Children's Hospital of Stanford University Palo Alto, California, United States
  • Ann & Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Illinois at Chicago Hospitals and Health Systems Chicago, Illinois, United States
  • Columbia University Medical Center (21+ years) New York, United States
View all 17 locations
View Trial Details
Completed

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05024045

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 23 locations
View Trial Details
Completed

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

NCT04684940

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Hemocentro Da UNICAMP Campinas, Brazil
  • Chaim Sheba Medical Center Ramat Gan, Israel
  • Kyung Hee University Hospital at Gangdong Seoul, South Korea
View Trial Details

Related conditions